2A eg) as girdles of mono- or multilayered cells. with increased overall survival in glioma-implanted recipient mice. Ectopic expression of IL-6 in IRE1-deficient tumors restored angiogenesis and neutralized vessel cooption but did not reverse the mesenchymal/infiltrative cell phenotype. The ischemia-responsive IRE1 protein is thus identified as a key regulator of tumor neovascularization and invasiveness. Keywords:tumor ischemia, unfolded protein response, mesenchymal drift Malignant gliomas are the most frequent primary brain tumors and represent a major challenge in cancer therapy. These deadly ARHA tumors exhibit the classic features of most solid cancers, including high (+)-Phenserine proliferation rate, angiogenesis, and invasiveness (1). Gliomas are characterized by diffuse infiltrative growth in the surrounding brain parenchyma, which precludes complete surgical resection and is responsible for local recurrences. A frequent feature of higher grade gliomas is their presentation of highly and abnormally vascularized lesions, a phenomenon that contributes to clinical malignancy by increasing interstitial fluid pressure, promoting vascular thrombosis followed by necrosis and occasionally inducing intracranial hemorrhages (24). As a consequence of these characteristics, gliomas are not easily accessible to current therapies. Antiangiogenic treatments, in combination with chemotherapy, have proven beneficial for patients suffering from high-grade tumors (5). However, angiogenesis inhibition may also have adverse effects by triggering invasive cell behavior (6,7). Indeed, inhibition or invalidation of key factors for angiogenesis such as the transcription factor HIF-1 (8,9), VEGF-A and its receptor KDR (912), VE-cadherin (13) and MMPs (14) enhances tumor invasion and cooption of blood vessels. A transition from invasive/coopting tumors to highly angiogenic tumors, which is a hallmark of glioma progression to glioblastoma, has also been modeled in animals (15). However, the molecular mechanisms underlying these seemingly mutually exclusive behaviors have not been elucidated. Most of the above-mentioned factors are functionally linked to VEGF-A activity (3,8), which provides a rationale for the molecular analysis of these phenotypic transitions. Expression signatures of invasive (15,16) and angiogenic (15,17,18) glioma cells and tissues also constitute critical frameworks for a comprehensive approach of these pathologic events. The existence of various invasion (+)-Phenserine and migration mechanisms (19) and redundant signals controlling the angiogenic switch (7) plead for therapeutic targeting of molecular functions acting at key branch points of these processes. Inositol-requiring enzyme 1 (IRE1, also named ERN1) is an endoplasmic reticulum (ER)-resident transmembrane protein acting as a proximal sensor of the unfolded protein response (UPR). As such, it participates in the early cellular response to the accumulation of misfolded proteins in the ER occurring under both physiological and pathological situations (20,21). Misfolded proteins in the ER lumen activate two distinct catalytic domains of IRE1, which display serine/threonine trans-autophosphorylation and endoribonuclease (RNase) activities, respectively. IRE1-associated RNase activity is involved in the degradation of a specific subset of mRNA (22) and also initiates the cytosolic splicing of the pre-XBP1 (X-box binding protein 1) mRNA whose mature transcript encodes a transcription factor that stimulates the expression of UPR-specific genes (20,21). Recently, single mutations inIRE1/ERN1gene were detected in human cancers, and IRE1 was proposed as a major contributor to tumor progression among protein kinases (23). Blockade of IRE1 transduction pathways in experimental tumor models suggests that its activity is linked to the neovascularization process (24). We now provide evidence that inhibition of IRE1 signaling results in the reduction in the number of functional tumor blood vessels in glioma and in the increase of tumor cell invasion and vessel cooption. The general aspect of these lesions exhibited similarities with the sarcomatous component in gliosarcomas, a rare biphasic variant of glioblastomas. This phenotypic transition correlates with the coordinate modulation of a variety of pro- and anti-angiogenesis factors. Transgene expression of the cytokine IL-6 in IRE1-deficient tumors was adequate to save (+)-Phenserine angiogenesis and also abolished vessel cooption. We propose IRE1 as a candidate regulator of angiogenesis and invasion in malignant gliomas in relation to its house to sense ischemia. == Results == == IRE1 Inhibition Induces Invasiveness and Prolongs Overall Survival of Glioma-Implanted Mice. == Inhibition of IRE1 signaling was connected to the manifestation of an IRE1 dominant-negative transgene in U87dn cells and was not observed in U87ctrl cells (Fig. S1). Both cell types were engrafted intracranially in mice, and tumor growth was analyzed. Surgical specimens from your U87ctrl tumors were typically homogenous and nodular with a high cellularity, round hyperchromatic nuclei and a razor-sharp demarcation from the surrounding mind parenchyma (Fig. 1A). No significant necrosis or apoptosis was recognized. This phenotype is definitely standard for U87 cell-derived tumors (observe alsoFig. 2). In contrast, U87dn tumors were diffuse, highly infiltrative and revealed a sarcomatous phenotype with densely packed long bundles of spindle cells. Cells experienced regular designs, loose cellular extensions characteristics of.
